Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-06-14
2005-06-14
Seaman, D. Margaret (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S418000, C514S217000, C514S217000, C514S321000, C514S322000, C514S323000, C540S575000, C540S602000, C540S603000, C544S370000, C544S373000, C546S199000, C546S201000, C548S306400, C548S486000, C548S485000
Reexamination Certificate
active
06906090
ABSTRACT:
The invention provides the use of certain isatin and oxindole derivatives in the preparation of a medicament for use in the treatment of mycobacterial disease.
REFERENCES:
patent: 4382934 (1983-05-01), Teraji et al.
patent: 5585378 (1996-12-01), Boar et al.
patent: 0432648 (1991-06-01), None
patent: 0503349 (1992-09-01), None
patent: 9312085 (1993-06-01), None
patent: WO 93/12085 (1993-06-01), None
patent: 9429272 (1994-12-01), None
patent: WO 94/29272 (1994-12-01), None
Piscopo et al., Boll. Soc. It. Biol. Sper. 52:1449-1455 (1986).
Verma et al., Indian J. Chem. 21B: 775-777 (1982).
Movrin et al., Pharmazie 34: 231-232 (1979).
AstraZeneca AB
Seaman D. Margaret
White & Case LLP
LandOfFree
Compositions and methods for treating mycobacterial diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for treating mycobacterial diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for treating mycobacterial diseases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3518452